Menu
Currency
GWAS Study

Genome-wide genetic investigation of serological measures of common infections.

Rubicz R, Yolken R, Drigalenko E et al.

25758998 PubMed ID
GWAS Study Type
1932 Participants
40 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RR
Rubicz R
YR
Yolken R
DE
Drigalenko E
CM
Carless MA
DT
Dyer TD
KJ
Kent J
CJ
Curran JE
JM
Johnson MP
CS
Cole SA
FS
Fowler SP
AR
Arya R
PS
Puppala S
AL
Almasy L
ME
Moses EK
KE
Kraig E
DR
Duggirala R
BJ
Blangero J
LC
Leach CT
GH
Göring HH
Chapter II

Abstract

Summary of the research findings

Populations and individuals differ in susceptibility to infections because of a number of factors, including host genetic variation. We previously demonstrated that differences in antibody titer, which reflect infection history, are significantly heritable. Here we attempt to identify the genetic factors influencing variation in these serological phenotypes. Blood samples from >1300 Mexican Americans were quantified for IgG antibody level against 12 common infections, selected on the basis of their reported role in cardiovascular disease risk: Chlamydia pneumoniae; Helicobacter pylori; Toxoplasma gondii; cytomegalovirus; herpes simplex I virus; herpes simplex II virus; human herpesvirus 6 (HHV6); human herpesvirus 8 (HHV8); varicella zoster virus; hepatitis A virus (HAV); influenza A virus; and influenza B virus. Pathogen-specific quantitative antibody levels were analyzed, as were three measures of pathogen burden. Genome-wide linkage and joint linkage and association analyses were performed using ~1 million SNPs. Significant linkage (lod scores >3.0) was obtained for HHV6 (on chromosome 7), HHV8 (on chromosome 6), and HAV (on chromosome 13). SNP rs4812712 on chromosome 20 was significantly associated with C. pneumoniae (P=5.3 × 10(-8)). However, no genome-wide significant loci were obtained for the other investigated antibodies. We conclude that it is possible to localize host genetic factors influencing some of these antibody traits, but that further larger-scale investigations will be required to elucidate the genetic mechanisms contributing to variation in antibody levels.

1,932 Mexican American individuals

Chapter III

Study Statistics

Key metrics and study information

1932
Total Participants
GWAS
Study Type
No
Replicated
Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.